Hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) breast cancer (BC) is defined by >1% expression of either estrogen receptors (ER) or progesterone receptors on the tumor cell surface. This evidence concerns the gene ESR1 and breast cancer.